MEG3: a novel long noncoding potentially tumour-suppressing RNA in meningiomas
Jazyk angličtina Země Spojené státy americké Médium print-electronic
Typ dokumentu časopisecké články, přehledy
- MeSH
- lidé MeSH
- lidské chromozomy, pár 14 genetika MeSH
- meningeom genetika MeSH
- nádory mozku genetika MeSH
- patologická angiogeneze genetika MeSH
- RNA dlouhá nekódující genetika MeSH
- signální transdukce genetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
- Názvy látek
- MEG3 non-coding RNA, human MeSH Prohlížeč
- RNA dlouhá nekódující MeSH
Meningiomas represent one of the most common types of primary intracranial tumours. However, the specific molecular mechanisms underlying their pathogenesis remain uncertain. Loss of chromosomes 22q, 1p, and 14q have been implicated in most meningiomas. Inactivation of the NF2 gene at 22q12 has been identified as an early event in their pathogenesis, whereas abnormalities of chromosome 14 have been reported in higher-grade as well as recurrent tumours. It has long been supposed that chromosome 14q32 contains a tumour suppressor gene. However, the identity of the potential 14q32 tumour suppressor remained elusive until the Maternally Expressed Gene 3 (MEG3) was recently suggested as an ideal candidate. MEG3 is an imprinted gene located at 14q32 that encodes a non-coding RNA (ncRNA). In meningiomas, loss of MEG3 expression, its genomic DNA deletion and degree of promoter methylation have been found to be associated with aggressive tumour growth. These findings indicate that MEG3 may have a significant role as a novel long noncoding RNA tumour suppressor in meningiomas.
Zobrazit více v PubMed
Curr Opin Oncol. 1995 Jan;7(1):76-82 PubMed
Cancer Res. 2003 Sep 15;63(18):5703-6 PubMed
Genome Res. 2000 Nov;10(11):1711-8 PubMed
Hum Mol Genet. 2005 Apr 15;14 Spec No 1:R121-32 PubMed
Mol Cell Endocrinol. 2010 Sep 15;326(1-2):40-7 PubMed
Genes Dev. 2006 Jan 1;20(1):16-21 PubMed
Cancer Res. 2005 Jan 1;65(1):26-33 PubMed
Clin Cancer Res. 1999 May;5(5):1231-40 PubMed
Am J Physiol Cell Physiol. 2004 May;286(5):C1089-99 PubMed
Oncogene. 1997 Feb 6;14(5):611-6 PubMed
Dev Dyn. 1998 Jun;212(2):214-28 PubMed
Science. 1998 May 15;280(5366):1035-6 PubMed
Mol Cell Biol. 1998 Feb;18(2):753-61 PubMed
Blood. 2001 Jul 15;98(2):422-7 PubMed
Leuk Res. 2010 Feb;34(2):148-53 PubMed
J Neurosurg. 1985 Jan;62(1):18-24 PubMed
Cell. 2004 Nov 24;119(5):591-602 PubMed
Cancer Res. 2002 Feb 15;62(4):1222-30 PubMed
Clin Lymphoma Myeloma. 2008 Jun;8(3):171-5 PubMed
Hum Mol Genet. 2002 Jun 15;11(13):1527-38 PubMed
Hum Mol Genet. 2002 Jan 1;11(1):77-86 PubMed
Oncogene. 2006 Aug 28;25(38):5220-7 PubMed
J Biol Chem. 2000 Jun 30;275(26):20127-35 PubMed
Acta Neuropathol. 2007 Aug;114(2):97-109 PubMed
Mol Cell Biochem. 2007 Aug;302(1-2):67-77 PubMed
Nucleic Acids Res. 1998 Aug 1;26(15):3453-9 PubMed
Oncogene. 1993 Sep;8(9):2353-60 PubMed
Nat Genet. 2003 Sep;35(1):97-102 PubMed
Br J Cancer. 2005 Apr 25;92(8):1574-80 PubMed
Brain Res. 2008 Jan 10;1188:25-34 PubMed
Endocrinology. 2010 Jun;151(6):2443-52 PubMed
Cancer Res. 2010 Mar 15;70(6):2350-8 PubMed
J Neurochem. 2000 Dec;75(6):2227-40 PubMed
Neurosurgery. 2009 Jan;64(1):56-60; discussion 60 PubMed
Surg Neurol. 1986 Nov;26(5):461-9 PubMed
EMBO J. 1998 May 1;17(9):2513-25 PubMed
Int J Biochem Cell Biol. 2006;38(10):1808-20 PubMed
J Biol Chem. 2007 Aug 24;282(34):24731-42 PubMed
Mutat Res. 2011 Feb 10;707(1-2):24-33 PubMed
Oncogene. 2001 Jul 5;20(30):4041-9 PubMed
Endocrinology. 2010 Mar;151(3):939-47 PubMed
Am J Pathol. 2004 Jun;164(6):2259-67 PubMed
Cell. 1995 May 5;81(3):323-30 PubMed
Mol Cancer Res. 2004 Jan;2(1):1-8 PubMed
J Cell Biochem. 2012 Jun;113(6):1868-74 PubMed
Oncogene. 2002 Jun 20;21(27):4212-9 PubMed
Int J Cancer. 2011 Aug 15;129(4):773-9 PubMed
Fertil Steril. 2002 Jul;78(1):114-21 PubMed
Semin Cancer Biol. 2003 Feb;13(1):49-58 PubMed
Nat Med. 1996 Aug;2(8):912-7 PubMed
J Clin Oncol. 2005 Jan 1;23(1):154-64 PubMed
Genome Res. 2001 May;11(5):850-62 PubMed
J Biol Chem. 2003 May 23;278(21):19358-66 PubMed
Proc Natl Acad Sci U S A. 2008 May 13;105(19):7004-9 PubMed
Int J Cancer. 2001 Oct 15;94(2):218-21 PubMed
Genes Dev. 1993 Jul;7(7A):1126-32 PubMed
Cancer. 2000 Sep 1;89(5):1102-10 PubMed
Proc Natl Acad Sci U S A. 1997 Dec 23;94(26):14719-24 PubMed
J Neurooncol. 2001 Dec;55(3):149-58 PubMed
J Clin Endocrinol Metab. 2003 Nov;88(11):5119-26 PubMed
J Neuropathol Exp Neurol. 2001 Jun;60(6):628-36 PubMed
J Clin Endocrinol Metab. 2008 Oct;93(10):4119-25 PubMed
J Clin Endocrinol Metab. 2005 Apr;90(4):2179-86 PubMed
Curr Opin Cell Biol. 2003 Apr;15(2):164-71 PubMed
Cancer Res. 1995 Oct 15;55(20):4696-701 PubMed
Trends Cell Biol. 2002 Jun;12(6):258-66 PubMed
Cell Death Differ. 2006 Jun;13(6):927-34 PubMed
Cancer Cell. 2002 Jul;2(1):9-15 PubMed
Genes Cells. 2000 Mar;5(3):211-20 PubMed
Nature. 1997 May 15;387(6630):296-9 PubMed
Nature. 2000 Nov 16;408(6810):307-10 PubMed
Science. 1996 Dec 6;274(5293):1672-7 PubMed
Nature. 1992 Jul 2;358(6381):80-3 PubMed